EQ-5D-5L和SF-6D量表的测量腺垂体功能减退患者生命质量及其影响因素分析
Status of Quality of Life and Its Influencing Factors in Patients with Hypopituitarism Measured by EQ-5D-5L and SF-6D Scales
DOI: 10.12677/ACM.2023.134803, PDF,   
作者: 王 姣：海南医学院第一临床学院，海南 海口；陈小盼*：海南医学院第一附属医院内分泌科，海南 海口
关键词: 腺垂体功能减退症；EQ-5D-5L；SF-6D；健康效用值；Hypopituitarism； EQ-5D-5L； SF-6D； Health Utility
摘要: 目的：采用EQ-5D-5L和SF-6D测量腺垂体功能减退症患者的健康效用值，评估生命质量，并分析其影响因素，比较两量表的适用性，为评估测量我国腺垂体功能减退患者生命质量工具提供参考依据。方法：以调查问卷形式，采用EQ-5D-5L及SF-6D量表计算于海南医学院第一附属医院就诊的腺垂体功能减退患者的健康效用值，进一步评估生命质量，采用Pearson相关系数、ICC组内相关系数评估两量表一致性，多元线性回归分析健康效用值影响因素。结果：共回收有效问卷147例，EQ-5D-5L和SF-6D测量腺垂体功能减退患者的平均健康效用值为(0.795 ± 0.154)，(0.808 ± 0.126)。两量表健康效用值测量结果有一定的相关性(r = 0.923, P < 0.01)，两量表ICC组内相关系数为0.904，一致性高。我国腺垂体功能减退患者生命质量影响因素为年龄、常住地、婚姻状况、文化程度、收入、是否遵医嘱用药、有无慢病。结论：我国腺垂体功能减退患者健康效用值较健康人群低，EQ-5D-5L及SF-6D量表所测得的健康效用值得分相关性及一致性较高，均可用于评估腺垂体功能减退患者生命质量。
Abstract: Objective: To measure the health utility values of patients with hypopituitarism by using EQ-5D-5L and SF-6D, assessing the quality of life, and analyzing the influencing factors, the applicability of the two scales was compared to provide a reference for evaluating and measuring quality of life tools in patients with hypopituitarism in China. Methods: The health utility values of patients with hypopi-tuitarism calculated at the First Affiliated Hospital of Hainan Medical College using the EQ-5D-5L and SF-6D scales in the form of a questionnaire. To further evaluate the quality of life, Pearson’s correlation coefficient and ICC intragroup correlation coefficient were used to evaluate the con-sistency of the two scales, and the influencing factors of health utility values were analyzed by mul-tiple linear regression. Results: A total of 147 validated questionnaires were collected, and the mean health utility values of patients with EQ-5D-5L and SF-6D were (0.795 ± 0.154) and (0.808 ± 0.126). The measured results of the health utility values of the two scales had some correlation (r = 0.923, P < 0.01), and the correlation coefficient within the ICC group of the two scales was 0.904, having high consistency. The factors influencing the quality of life of patients with hypopituitarism in China are age, permanent residence, marital status, educational level, income, whether they fol-low medical advice, and whether they are chronic. Conclusion: The health utility value of Chinese patients with hypopituitarism is lower than that of healthy people. The EQ-5D-5L and SF-6D scales can be used to assess the quality of life in patients with hypopituitarism.
文章引用：王姣, 陈小盼. EQ-5D-5L和SF-6D量表的测量腺垂体功能减退患者生命质量及其影响因素分析[J]. 临床医学进展, 2023, 13(4): 5686-5693. https://doi.org/10.12677/ACM.2023.134803

参考文献

[1] Regal, M., Páramo, C., Sierra, S.M., et al. (2001) Prevalence and Incidence of Hypopituitarism in an Adult Caucasian Population in Northwestern Spain. Clinical Endocrinology, 55, 735-740. [Google Scholar] [CrossRef] [PubMed]
[2] 杨喜平, 曾世鸿, 李飞. 医护一体化住院患者护理评估信息系统的应用与效果[J]. 实用医院临床杂志, 2019, 16(4): 260-262.
[3] 贾文娟, 刘峰, 郑方平, 等. 腺垂体功能减退性危象临床分析[J]. 中国实用医药, 2019, 14(18): 64-65.
[4] 叶梓. 医护一体化护理对腺垂体功能减退症患者症状和生活质量的影响评价[J]. 养生保健指南, 2021(8): 197.
[5] 王诗蕊, 朱惠娟. 垂体前叶功能减退的临床诊治进展[J]. 临床内科杂志, 2022, 39(8): 508-511.
[6] 张艳, 高珊, 鲁文菊, 等. 腺垂体功能减退症患者的延续性健康管理[J]. 护理学杂志, 2015, 30(15): 26-28.
[7] Wei, I.H. and Huang, C.C. (2022) Risk of Mental Illnesses in Patients with Hypopituitarism: A Nationwide Population-Based Cohort Study. Psychiatry Investigation, 19, 418-426. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, H.M., Patrick, D.L., Edwards, T.C., et al. (2012) Validation of the EQ-5D in a General Population Sample in Urban China. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 21, 155-160. [Google Scholar] [CrossRef] [PubMed]
[9] 叶子平, 郑义, 孙利华. 六维健康状态分类系统SF-6D介绍及研究现状[J]. 中国卫生经济, 2018, 37(2): 70-73.
[10] 张崖冰, 胡善联. 用不同测量方法得到的效用值的比较[J]. 中国卫生经济, 2014, 33(3): 5-8.
[11] Brazier, J., Roberts, J. and Deverill, M. (2002) The Estimation of a Preference-Based Measure of Health from the SF-36. Journal of Health Economics, 21, 271-292. [Google Scholar] [CrossRef] 
[12] 周挺, 官海静, 刘国恩, 等. 基于EQ-5D量表的中国疾病人群生命质量系统评价[J]. 中国循证医学杂志, 2016, 16(2): 135-142.
[13] 杨智豪, 蒋杰, 洪艳明, 等. 中国成本-效用研究中效用值质量的现状和展望[J]. 中国药物经济学, 2022, 17(6): 33-40.
[14] 杨柳, 张凌, 杨猛, 等. 基于欧洲五维度五水平健康量表评估难治性继发甲状旁腺功能亢进患者生命质量[J]. 中国血液净化, 2021, 20(11): 742-745.
[15] 顾杰, 姜林娣. 健康状况的效用值和测量方法[J]. 中华行为医学与脑科学杂志, 2009, 18(1): 84-85.
[16] 张杰, 孙权, 等. 关节炎健康效用值映射法转换的研究进展[J]. 沈阳药科大学学报, 2021, 38(1): 81-85.
[17] 姚强, 张耀光, 徐玲. 中国居民健康相关生命质量状况及影响因素研究——基于国家卫生服务调查实证分析[J]. 人口与发展, 2018, 24(3): 85-95.

为你推荐